File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1007/978-3-642-29305-4_599
- Scopus: eid_2-s2.0-84876020076
- Find via
Supplementary
-
Citations:
- Scopus: 0
- Appears in Collections:
Conference Paper: Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials
Title | Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials |
---|---|
Authors | |
Keywords | quality Surgery SBRT NSCLC clinical trials |
Issue Date | 2013 |
Citation | IFMBE Proceedings, 2013, v. 39 IFMBE, p. 2284-2287 How to Cite? |
Abstract | Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies. © 2013 Springer-Verlag. |
Persistent Identifier | http://hdl.handle.net/10722/266958 |
ISSN | 2023 SCImago Journal Rankings: 0.137 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Xiao, Y. | - |
dc.contributor.author | Yin, F. | - |
dc.contributor.author | Kong, F. M.S. | - |
dc.contributor.author | Yue, J. | - |
dc.contributor.author | Galvin, J. | - |
dc.date.accessioned | 2019-01-31T07:20:05Z | - |
dc.date.available | 2019-01-31T07:20:05Z | - |
dc.date.issued | 2013 | - |
dc.identifier.citation | IFMBE Proceedings, 2013, v. 39 IFMBE, p. 2284-2287 | - |
dc.identifier.issn | 1680-0737 | - |
dc.identifier.uri | http://hdl.handle.net/10722/266958 | - |
dc.description.abstract | Clinical evidence have shown SBRT to be a tolerable, efficacious, and promising non-invasive therapy. Randomized prospective studies comparing surgery vs. SBRT in early-stage lung cancer are proposed to further investigate the relative survival, quality of life, and cost characteristics of these treatment paradigms. Accreditation and dosimetry requirements were carefully vetted for RTOG SBRT trials. Advanced technologies introduced since have posed additional challenges. This study provides an overview of the quality requirements including those for the recently introduced technologies. © 2013 Springer-Verlag. | - |
dc.language | eng | - |
dc.relation.ispartof | IFMBE Proceedings | - |
dc.subject | quality | - |
dc.subject | Surgery | - |
dc.subject | SBRT | - |
dc.subject | NSCLC | - |
dc.subject | clinical trials | - |
dc.title | Quality requirements for stereotactic body radiation therapy (SBRT) in multi-institutional clinical trials | - |
dc.type | Conference_Paper | - |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1007/978-3-642-29305-4_599 | - |
dc.identifier.scopus | eid_2-s2.0-84876020076 | - |
dc.identifier.volume | 39 IFMBE | - |
dc.identifier.spage | 2284 | - |
dc.identifier.epage | 2287 | - |
dc.identifier.issnl | 1680-0737 | - |